Interferon α (IFN-α) vs. the combination IFN-α and octreotide LAR in the treatment of patients with well differentiated neuroendocrine tumors (NET) of various localizations

It is still unknown whether the combination of IFN-α with octreotide has benefit compared with IFN-α alone. We compared efficacy and toxicyty of IFN-α and IFN-α plus octreotide in first line of therapy of patients with NETs. There was trend to longer TTP in lung NETs pts comparing with GEP NETs pts...

Full description

Bibliographic Details
Main Authors: G S Yemelyanova, A E Kuzminov, N F Orel, A A Markovich, A A Kuznetsova, V A Gorbunova
Format: Article
Language:Russian
Published: IP Habib O.N. 2017-06-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/27153/pdf